The group has more than 300 types of medical devices and drugs in more than 30,000 specifications, mainly including infusion consumables, operating room series, medical catheters, cardiac stents and intracardiac consumables, indwelling needles and various special-shaped needles, Blood purification equipment and consumables, orthopedic materials, medical equipment, therapeutic injections and other drugs, biological diagnostic reagents, artificial plasma, biological implants, PVC and non-PVC raw materials and other series have become the most complete, safe, reliable and most valuable products in the world. Trust, the largest manufacturer of medical system solutions in China, is a national 863 industrialization base and a key high-tech enterprise in the National Torch Plan. It has successively won the titles of Industry Pioneer Enterprise, Sanitary Materials and Pharmaceutical Manufacturing Industry Pioneer Enterprise, National Contract-abiding and Credit-worthy Enterprise, China Top 500 Most Competitive Enterprise Groups, Top 100 National Pharmaceutical Industry (No. 6), Top 500 Chinese Enterprises Informatization, Top 500 National Private Enterprises, China’s Patented Shandong Star Enterprise, and China’s No. 1 Medical Device Brand Supplier with the Most Bidding Power Honorary titles such as the Shandong Province Industry-University-Research Cooperation Innovation Outstanding Contribution Award, Shandong Province Top 100 Enterprises, Shandong Province Best Corporate Citizen, and Shandong Province’s first batch of integrity demonstration enterprises.
The company vigorously implements the famous brand strategy, strengthens scientific management, adheres to the quality policy of "meeting and striving to exceed the greatest needs of customers", and establishes and improves the quality management system. Since 1998, its main products have passed ISO9000, EU CE certification, ISO13485 quality system certification, China CMD certification, China 3C certification, and GMP certification. Some products have passed the US FDA510 license, and it is the first company in the industry to pass ISO9000 certification. The testing center is accredited by the National Laboratory Accreditation Board. The "Jierui" trademark is a well-known trademark in China, the number one brand in China's medical device industry, China's famous brand product, and the number one company with the most bidding power in China's medical device industry. Products are exported to more than 70 countries and regions abroad.
The company has a sound technological innovation system, with a national technology center, a national engineering laboratory, a postdoctoral workstation, a Shandong academician workstation, a provincial enterprise technology center, and a Taishan Scholars Laboratory. Adhering to the path of industry-university-research cooperation, we have cooperated with the Chinese Academy of Sciences and its Changchun Institute of Applied Chemistry, Dalian Institute of Chemical Physics, Shenyang Institute of Metal Research, 301 Hospital, Third Military Medical University, Harbin Institute of Technology, Shenyang Pharmaceutical University, etc., and established 9 Weigao in remote locations. R&D center, vigorously develop high-tech and high value-added products with independent intellectual property rights. In 2010, we jointly implemented the Chinese Academy of Sciences-Weigao Group high-tech research and development plan with the Chinese Academy of Sciences to further enhance our independent innovation capabilities. At present, Weigao has more than 200 patented products, including 60 invention patents. More than 80 products have filled domestic gaps and reached advanced levels at home and abroad. Some products have broken the monopoly of multinational companies. More than 20 projects (cardiac stents, polysulfone Membrane dialyzers, spinal internal fixation, central venous catheters, gene protein A immunoadsorption columns, self-destructive safety syringes, plasma separators, light-proof syringes, etc.) are included in the National Key Torch Plan, the National 863 Plan, and the National High-tech Industry Demonstration projects, national key industry revitalization plans and other national planning projects.
The company implements the strategy of going global, strengthens international cooperation, and has established strategic cooperative relationships with Medtronic of the United States, Biosensors International of Singapore, Nikkiso Co., Ltd. of Japan, True Vision of the United States, and Korean IT companies, etc. It has established R&D centers in the United States, Japan, the United Kingdom, Germany, and France to absorb advanced medical technologies from around the world.
Weigao Group actively participates in social welfare and charity to repay the society. In recent years, Weigao Bright Action, Weigao Love Project, selection of top ten filial piety stars, subscription of charity funds, natural disaster donations and other activities have been carried out, with a total of more than 200 million yuan in donations.
Weigao takes "together with the messengers in white to create a healthy future" as its mission, establishes the core corporate values ??of conscience, sincerity and loyalty, builds a century-old evergreen foundation, and strives to become "world competitive, Asia-leading, The vision goal of "the most respected medical device and pharmaceutical enterprise" is making great progress and making greater contributions to promoting the healthy development of my country's medical and health industry.